"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -38,341 (-0.2%)","  -2,196 (-6.9%)","  -4,470 (-4%)","    -246 (-10.5%)","  -2,150 (-7.6%)"
"2","50% prioritisation"," -31,350 (-0.2%)","  -2,248 (-7.1%)","  -4,554 (-4%)","    -252 (-10.7%)","  -2,201 (-7.8%)"
"3","75% prioritisation"," -27,427 (-0.2%)","  -2,265 (-7.2%)","  -4,576 (-4%)","    -254 (-10.8%)","  -2,218 (-7.9%)"
"4","booster at three months (at risk only)","-440,627 (-2.5%)","  -8,288 (-26.2%)"," -16,802 (-14.9%)","    -903 (-38.4%)","  -7,916 (-28%)"
"5","additional primary doses"," -20,909 (-0.1%)","  -2,261 (-7.1%)","  -4,658 (-4.1%)","    -251 (-10.7%)","  -2,202 (-7.8%)"
"6","additional booster doses","-552,709 (-3.2%)","  -8,269 (-26.1%)"," -17,626 (-15.6%)","    -878 (-37.3%)","  -7,821 (-27.7%)"
"7","broaden to <18 pregnant individuals"," -20,909 (-0.1%)","  -2,261 (-7.1%)","  -4,658 (-4.1%)","    -251 (-10.7%)","  -2,202 (-7.8%)"
